DUBLIN--(BUSINESS WIRE)--The "Hospital-Acquired Infection Diagnostics Market by Product, by Test Type, by Application, by Infection Type, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2016-2023" report has been added to ResearchAndMarkets.com's offering.
The growth in the market will be led by the increase in incidences of infections caused in clinical settings, especially in developing economies owing to their poor hygiene facilities.
On the basis of test type, the HAI diagnostics industry has been categorized molecular diagnostics, urinalysis, and immunoassay. Due to the high prevalence rate of HAI such as, bloodstream infections, surgical site infections, gastrointestinal Infections, and urinary tract infections (UTI), the immunoassay segment was the highest contributor accounting for $1,195 million in 2016 and is expected to reach $1,686.2 million by 2023.
In terms of product, the HAI diagnostics market has been categorized into instrument and reagents and consumables. The reagents and consumables dominated the market in 2016 with a share of 63.1%. The rise in the number of patients suffering from various infectious diseases such as bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), which increases the demand for reagents & consumables with growth in molecular diagnostic testing volumes. It is also expected to maintain the same trend throughout the forecast period, registering a high CAGR of 8% during 2017-2023.
The HAI diagnostics market based on application is segmented into disease testing and drug-resistance testing. The drug-resistance testing application dominated the market with 79.8% share in 2016 and is expected to maintain the same trend throughout the forecast period.
Key Topics Covered
1. Research Background
2. Research Methodology
3. Executive Summary
5. Global Market Size and Forecast
6. North America Market Size and Forecast
7. Europe Market Size and Forecast
8. APAC Market Size and Forecast
9. LAMEA Market Size and Forecast
10. Competitive Landscape
11. Company Profiles
- Abbott Laboratories
- AstraZeneca plc
- Bayer AG
- Becton, Dickinson and Company
- Daiichi Sankyo Co. Ltd.
- Danaher Corporation
- Hologic Inc.
- Johnson & Johnson
- OpGen, Inc.
- F. Hoffmann La-Roche AG
For more information about this report visit https://www.researchandmarkets.com/research/9ghfvs/global?w=4